Asger Wretlind

8PUBLICATIONS

54CO-AUTHORS

Central nervous systemPredictive and prognostic markersMedical biochemistry - carbohydratesMetabolic medicineMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 18, 2026

Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition.

|Jul 21, 2023

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.

Asger Wretlind, Viktor R Curovic, Tommi Suvitaival

|May 03, 2023

Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Roderick C Slieker, Louise A Donnelly, Elina Akalestou

|Apr 26, 2022

Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion.

Eleni Georgiadou, Charanya Muralidharan, Michelle Martinez

|Sep 14, 2021

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial.

Emilie H Zobel, Asger Wretlind, Rasmus S Ripa

|Aug 28, 2021

Intravital imaging of islet Ca2+ dynamics reveals enhanced β cell connectivity after bariatric surgery in mice.

Elina Akalestou, Kinga Suba, Livia Lopez-Noriega

Pageof 2

Frequent Collaborators

Guy A Rutter

Eleni Georgiadou

Roderick C Slieker

Hugo Fitipaldi

Gerard A Bouland

Mathias J Gerl

Ashfaq Ali

Leif Groop

Peter Rossing

Timothy J Pullen

Frequent Collaborators

Guy A Rutter

Eleni Georgiadou

Roderick C Slieker

Hugo Fitipaldi